Skip to content

Amycretin

Also called Amylin / GLP-1 unimolecular

Single molecule hitting both amylin and GLP-1 receptors.

  • TypePeptide
  • FormInjectable
  • Researched forMetabolic & Fat Loss
Join Skool for the protocol

No partner carries Amycretin yet.

The short version

  • Why people research itFat oxidation, appetite and energy regulation, insulin sensitivity and endurance capacity.
  • What the evidence isIn phase 3 as of 2025.
  • What to watchSevere upper abdominal pain that radiates to the back.

How Amycretin works

Single molecule hitting both amylin and GLP-1 receptors — additive appetite suppression via different brain circuits; oral and injectable forms.

Amycretin is one molecule that activates the GLP-1 receptor and the amylin receptor, and the published preclinical work says it activates a third one that nobody mentions. In cell-based systems it activated human, mouse and rat GLP-1, amylin AND calcitonin receptors Kuhre 2025.

There is no such gene as ‘the amylin receptor’. An amylin receptor is the calcitonin receptor (CTR) with a receptor-activity-modifying protein bolted onto it: CTR plus RAMP1 is AMY1, plus RAMP2 is AMY2, plus RAMP3 is AMY3. The same seven-transmembrane protein, three different accessory subunits, four different pharmacologies.

  • Injectable

On the goal map: Appetite & satiety signaling (Lose fat)

Where to get Amycretin

No partner carries it yet.

When a vetted partner does, the link and code go here.

Research on Amycretin6 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Evidence on file: Phase 1/2 human (~10-13% in 12 wks).

Human clinical evidence

  • In phase 3 as of 2025. Novo Nordisk's single-molecule GLP-1 and amylin co-agonist. Early phase 1/2 results generated unusual attention: the subcutaneous form reported around 22% weight loss at 36 weeks, and an oral form showed roughly 13% at 12 weeks.

  • These are early, small. Phase 1 weight numbers have repeatedly failed to hold at phase 3 scale across this entire field, so the figure to watch is the phase 3 readout, not the headline.

Correlative data

  • No real-world use at all. Trial reports describe class-typical GI effects.

How the mechanism reads

  • One molecule hitting two receptors — GLP-1 and the amylin receptor — rather than co-formulating two drugs as CagriSema does.

    Mechanistic
  • Amylin and GLP-1 suppress appetite through genuinely separate pathways: GLP-1 acts largely on hypothalamic and hindbrain circuits, amylin on the area postrema. Hitting both is additive rather than redundant, which is the mechanistic case for the larger effect size.

    Mechanistic
  • A single molecule also means one pharmacokinetic profile to manage instead of two, which is a real formulation advantage if the ratio is right.

    Mechanistic

Sources

  • Gasiorek A, et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial. The Lancet 2025 · PMID 40550229
  • Dahl K, et al. Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study. The Lancet 2025 · PMID 40550231
  • Kuhre RE, et al. The effect of amycretin, a unimolecular glucagon-like peptide-1 and amylin receptor agonist, on body weight and metabolic dysfunction in mice and rats. EBioMedicine 2025 · PMID 40706446
  • Cao J, et al. Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors. Nature Communications 2025 · PMID 40204768
  • Gu YM, et al. Structural and mechanistic insights into dual activation of cagrilintide in amylin and calcitonin receptors. Acta Pharmacologica Sinica 2025 · PMID 40847076
  • Awida Z, et al. The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice. International Journal of Molecular Sciences 2021 · PMID 35008482

Amycretin safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Medullary thyroid cancer or MEN2 in you or a relative, the GLP-1 receptor class warning.
  • Past pancreatitis.
  • Type 1 diabetes, insulin or sulfonylurea use, because intake falls and low blood sugar becomes likely.
  • Gastroparesis or severe gut motility disease.
  • Pregnancy or planning one soon, as appetite suppression cuts nutrient supply.

What’s expected

  • Reduced appetite and early fullness from combined GLP-1 and amylin signaling.
  • Nausea, which drove many dropouts in the subcutaneous study.
  • Constipation or loose stool as gastric emptying slows.

Watch for

  • Severe upper abdominal pain that radiates to the back.
  • Repeated vomiting that leaves you dehydrated.
  • A neck lump, hoarseness or trouble swallowing.

Labs that tell you it’s working

  • HbA1c: the efficacy marker for any incretin-based agent.
  • Lipase: pancreatic enzyme if abdominal pain appears.
  • Comprehensive Metabolic Panel: kidney function and electrolytes during poor intake or vomiting.
  • Insulin (Fasting): shows insulin sensitivity improving as weight falls.

Unimolecular GLP-1 and amylin receptor co-agonist: additive satiety through two brainstem and hypothalamic routes plus slowed gastric emptying. PMID 40550229 PMID 40550231

Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON

A panel picked from how it works and what it can move: the tests, and why each is on it.

9 tests in one order
Marek Diagnostics · no doctor’s visit
Code CAMERON
Order this panel

Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.

The Metabolic Health & Prediabetes panel, explained

Amycretin FAQ4 common questions

Is Amycretin approved for human use?
No. Amycretin is a research compound.
What is Amycretin researched for?
Fat oxidation, appetite and energy regulation, insulin sensitivity and endurance capacity.
Which labs show whether it's doing anything?
HbA1c; Lipase; Comprehensive Metabolic Panel; Insulin: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for Amycretin: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what Amycretin is. Skool covers how it is run.

Free on this page

What Amycretin is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What Amycretin is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The protocols: what to run together, in what order, for how long and when to stop
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Join Skool for the protocol